Adma Biologics (ADMA) Preferred Shares (2011 - 2020)
Adma Biologics' (ADMA) quarterly Preferred Shares came in at $8222.0 in Q4 2011.
Analysis
Adma Biologics (ADMA) Preferred Shares (2011 - 2020) Analysis & Trends
Adma Biologics (ADMA) has 1 years of Preferred Shares data on file, last reported at $8222.0 in Q4 2011.
- Quarterly Preferred Shares changed N/A year-over-year to $8222.0 in Q4 2011, while the trailing twelve-month figure through Dec 2011 was $8222.0 (changed N/A YoY) and the FY2011 annual result came in at $8222.0, changed N/A from the prior year.
- Preferred Shares steadied at $8222.0 in Q4 2011.
- In the past five years, Preferred Shares ranged from a high of $8222.0 in Q4 2011 to a low of $8222.0 in Q4 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | - |
| 10 | Adma Biologics | 2.18 Bn | 2.05 Bn | 86.28 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | 10.00 Mn |
| Dec 31, 2019 | 10.00 Mn |
| Dec 31, 2011 | 8,222.00 |